Title: Beyond the breakthrough: How to protect, commercialize, and value IP and other intangible assets
Abstract:
Amid the evolving landscape of the BioTech industry, key trends are shaping its trajectory. The interplay of AI, data science and biotech is reshaping diagnostics, drug discovery and personalized medication, offering data-driven insights and transformative solutions. With enhanced efficiencies in the analysis of complex biological data, accelerated drug development, and the enabling of personalized treatment approaches, BioTech and Bioengineering companies that can harness and protect their innovations are set to dominate the sector.
Concurrently, a pronounced emphasis on sustainability is influencing eco-friendly practices and technologies within the biotech landscape. From manufacturing processes to waste reduction, sustainability is becoming integral to industry practices, aligning with environmental consciousness and regulatory expectations.
Unifying these trends is the core recognition that the value of these innovations or operational processes resides in intangible assets (such as intellectual property, data, brand, approvals & certifications, relationships, systems & processes and more). However, these assets are often off balance sheet, under-utilised and under-valued, in effect making their value somewhat invisible.
This session will focus on how to make the valuable visible within a BioTech or BioEngineering company. The focus will be on what happens after you have achieved a scientific breakthrough. How do you recognise where exactly the value in the innovation lies and how can you then protect it in order to commercialize and extract the value. The speaker will provide insights, case studies and practical advice regarding the challenges and opportunities inherent in identifying, protecting, commercialising, and valuing intangible assets.
Audience Take Away Notes:
- How to identify and protect the critical intangible assets driving value within BioTech companies (such as intellectual property, data, brand, approvals & certifications, relationships, systems & processes and more)
- Commercialisation pathways and why it is important to assess the ROI on each before getting locked into a strategy
- Techniques to identify and unlock the hidden value within your business and how to articulate this to potential investors, acquirers or partners to ultimately drive an increased valuation
